Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. - Wikidata - awgldk - TriplyDB

Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting.

Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting.

http://www.wikidata.org/entity/Q40891663

about

In Vivo Rodent Models of Skeletal Muscle Adaptation to Decreased Use Aerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and Differences Optimizing IGF-I for skeletal muscle therapeutics Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?Cellular and molecular mechanisms of muscle atrophy Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?Role of IGF-I signaling in muscle bone interactions The renin-angiotensin system and prevention of age-related functional decline: where are we now?Glucocorticoid-induced leucine zipper (GILZ) and long GILZ inhibit myogenic differentiation and mediate anti-myogenic effects of glucocorticoids Reactive Oxygen Species/Nitric Oxide Mediated Inter-Organ Communication in Skeletal Muscle Wasting Diseases.PGC-1α promotes nitric oxide antioxidant defenses and inhibits FOXO signaling against cardiac cachexia in mice.Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile Proteasome inhibitors and cardiac cell growth Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure.Protein calorie malnutrition, nutritional intervention and personalized cancer care.A limited role for PI(3,4,5)P3 regulation in controlling skeletal muscle mass in response to resistance exercise.Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy Angiotensin-II-induced Muscle Wasting is Mediated by 25-Hydroxycholesterol via GSK3β Signaling Pathway.Satellite cells and the muscle stem cell niche IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression.PTEN inhibition improves muscle regeneration in mice fed a high-fat diet.Activated protein synthesis and suppressed protein breakdown signaling in skeletal muscle of critically ill patients Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease.An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.Caspase-3 cleaves specific 19 S proteasome subunits in skeletal muscle stimulating proteasome activity.The link of unintentional weight loss to cardiac event-free survival in patients with heart failure Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy 1-Sarcosine-angiotensin II infusion effects on food intake, weight loss, energy expenditure, and skeletal muscle UCP3 gene expression in a rat model Angiotensin type 2 receptor signaling in satellite cells potentiates skeletal muscle regeneration.A randomized controlled trial of angiotensin-converting enzyme inhibition for skeletal muscle dysfunction in COPD.Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failure Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure Mechanisms of muscle wasting in chronic kidney disease Chronic heart failure reduces Akt phosphorylation in human skeletal muscle: relationship to muscle size and function Proteasome inhibition improves diaphragm function in congestive heart failure rats.Protein phosphatase 2C-alpha knockdown reduces angiotensin II-mediated skeletal muscle wasting via restoration of mitochondrial recycling and function Angiotensin II induced catabolic effect and muscle atrophy are redox dependent.The regulation of muscle mass by endogenous glucocorticoids.Angiotensin II upregulates protein phosphatase 2Cα and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wasting Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia

P2860

Q26753187-142B513A-9CBD-41F0-9536-9C6C34184154 Q26767412-7DBFBA15-14B3-4F2E-82E5-38C8A276E84C Q26825444-5E9EC03D-EE26-4999-906F-868C0B5D78DB Q26866208-C46C8B90-DA6D-462D-B4B5-CD7DD1195904 Q27012762-76A76F76-301B-41A6-BDA8-939D327834B6 Q28068034-CE9FED32-0549-4583-BF91-95298737AD13 Q28082188-A3094A44-BD64-4EDC-80A8-7013EEE486A1 Q28085528-A50CBDD3-6870-4975-814B-4D314523F078 Q28509978-26C6FEFF-1DE1-4D3F-866B-C92F4EBED29A Q30275433-58B25918-96CA-4802-8689-8AD9F77B6A91 Q30427538-FB9AB76A-FC4A-459D-B0BA-84DC86F6AFC6 Q30440296-76E01162-BC4F-4EF1-A889-545458282901 Q33554490-7D1FC707-F2AC-411E-9590-FB369D6701DF Q33559582-93E5B607-46A2-4206-896B-48F755FEE63F Q33618955-E746586E-8048-4E25-B22B-D96B03BF7E46 Q33641237-80E9E3FC-D41B-4C23-A162-BCBB6BA68B72 Q33702390-E8613813-D289-48A4-8077-80DA232936DE Q33809770-0FF420D5-35E7-4C32-9252-719ECCFCBF31 Q33816665-9A45BC94-7800-4E34-9B3C-0B907AB71E0C Q33840703-E53FDAA3-C21C-402F-8A51-BCFFA0D86955 Q33869719-3D7515BD-F1A6-440B-8785-060D2649BEF3 Q33869877-994D0B6A-D3BD-43EF-8B55-D0036A5D5442 Q33885504-87ED44F4-655D-4438-B9DC-CBE8BCDDA5FE Q33901722-4D13FA7E-351C-4E44-8567-46CEA77B7894 Q33967411-ECBF4C50-559B-4040-A25F-A836E5C5EA7A Q34036472-0B4AD78D-C9A8-4358-9600-FFFCDFC0EF8C Q34140453-84F70894-1C90-4A3A-BFB0-0D551617FFD0 Q34156951-CA1597A8-72BA-4F30-86A9-11D4C13C7A94 Q34248966-1D2DDBA0-5702-4930-AA16-2AFA8E56D0D3 Q34299825-A83FE71B-5999-42B4-BC4C-9B3831BD8205 Q34590981-71CB0FA4-B046-4B0F-9E93-73B3ABA84216 Q34667465-4974562B-EE67-4174-8475-D3885FD145BD Q34723810-A788719F-6BBA-4ED9-BB68-4B87DD8EE3CB Q34785071-A24D89F4-CBBD-4225-B770-8109730F5755 Q35005523-0D55279E-41EF-40B9-B071-251E11255943 Q35011884-542DEB82-B496-44A0-A7AA-A8F7FACE491A Q35028013-62C76018-ED18-46D3-8C82-EB4F555A1494 Q35042169-4A2B078A-E5A7-47A4-AF8B-D24D005D1D9E Q35240148-AEA5C450-87FB-4B1F-81E9-97EE83FCADC6 Q35536351-BF7C74DF-EA3C-46CC-8075-4E84E44F98E6

P2860

Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting.

http://www.wikidata.org/entity/Q40891663

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Muscle-specific expression of ...... duced skeletal muscle wasting.

@en

type

label

Muscle-specific expression of ...... duced skeletal muscle wasting.

@en

prefLabel

Muscle-specific expression of ...... duced skeletal muscle wasting.

@en

P1433

Q40891663-EE0A23DE-0DE9-49C5-B6DE-9C791C77920B

P1476

Q40891663-D9686E3A-FDCF-41FB-ACB7-97327E3C50F1

P2093

Q40891663-19C4176F-F06E-4B34-AF87-4B039E84DC62

Q40891663-251853C8-0AF8-4DF1-9E56-638FF630B05F

Q40891663-56DCD1AE-1046-4C95-9319-A81F7398CFA7

Q40891663-5E341897-DA0A-4D09-A5DE-9E295982A705

Q40891663-E84A9480-FDEF-4CE5-B32B-9352273568B2

P2860

Q40891663-00543268-ED41-436A-B455-C184BDE5E290

Q40891663-0B82991D-3CB3-485F-AD92-78017500521C

Q40891663-0C52EDA3-71F9-41C4-A509-BDE9EEACF2AB

Q40891663-11B07EA8-9A8F-411C-A0D7-B0D81516BC0D

Q40891663-16F32C2A-2AD2-484C-893B-941DB5754933

Q40891663-1D7EA03A-FE8D-4C71-85CF-9B8205EE417C

Q40891663-25275200-D7EC-4DEC-9D61-563750ECC297

Q40891663-256D9D49-ADE9-43A7-B4DD-B7283DF665D6

Q40891663-2661F18E-E40A-4F01-B01E-285ADE27455C

Q40891663-32A578DA-F3BB-4C76-9AE5-008A9A32AFC5

P304

Q40891663-FB97F3FB-1940-4A2A-9E26-1A6153BB075C

P31

Q40891663-4F216CD2-7595-446E-9C5B-ACB5D3603FA7

P356

Q40891663-8EB73D65-8621-4C7E-9F28-8803566BAB8B

P407

Q40891663-F53F3054-14FB-4BD8-8A58-B61666F185BA

P433

Q40891663-6DDDE50B-2D6C-48E7-9284-1742380ECD53

P478

Q40891663-385ECDB8-0D02-41D4-9322-8712DF0A5E9D

P50

Q40891663-94301578-926A-4CFA-AB59-C24DC4B42AA9

P577

Q40891663-2B5F8FA2-C369-4CE4-AC6D-6F89FA813ED7

P698

Q40891663-F2C23F55-BA95-4F7F-BAE1-8692D8150514

P932

Q40891663-39C04945-24D6-400D-914B-E67D7DB9BF6B

P356

P1433

Journal of Clinical Investigation

P1476

Muscle-specific expression of ...... duced skeletal muscle wasting.

@en

P2093

Jie Du

http://www.w3.org/2001/XMLSchema#string

Patrick Delafontaine

http://www.w3.org/2001/XMLSchema#string

William E Mitch

http://www.w3.org/2001/XMLSchema#string

Yangxin Li

http://www.w3.org/2001/XMLSchema#string

Yao-Hua Song

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatocarcinogenic potential of the glucocorticoid antagonist RU486 in B6C3F1 mice: effect on apoptosis, expression of oncogenes and the tumor suppressor gene p53

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

The calpain system

Signalling pathways that mediate skeletal muscle hypertrophy and atrophy

Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt

Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression

Identification of ubiquitin ligases required for skeletal muscle atrophy

Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy

Amino acids stimulate translation initiation and protein synthesis through an Akt-independent pathway in human skeletal muscle.

Insulin and insulin-like growth factor-I enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms.

P304

451-458

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI22324

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P50

Nadia Rosenthal

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15650772

http://www.w3.org/2001/XMLSchema#string

P932

544037

http://www.w3.org/2001/XMLSchema#string